Medarex Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of fully human antibody-based therapeutic product candidates. As of December 31, 2007, over 40 antibody product candidates generated from the Company’s UltiMAb technology are in human... more

Corixa (Nasdaq: CRXA) is a developer of immunotherapeutics with a commitment to treating and preventing cancer and infectious diseases by understanding and directing the immune system. On June 30, 2003, Corixa announced that the FDA approved BEXXAR for the treatment of patients with CD20... more

CancerVax Corporation is a leading edge biotechnology company focused on the discovery, development and commercialization of products for the treatment and control of cancer. CancerVax Corporation is firmly committed to building value by developing innovative products that extend life... more

Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. The Company has four clinical development programs, including three late-stage... more

Isis Pharmaceuticals, Inc. (Isis) is a biopharmaceutical company engaged in antisense technology, exploiting a drug discovery platform to create a pipeline of drugs. In addition to its antisense programs, the Company maintains technology leadership beyond its core areas of focus through... more

Almac has the most comprehensive range of integrated drug development services available to the biopharmaceutical industry. Employing over 2,000 highly skilled individuals, the privately owned company is headquartered in Craigavon, Northern Ireland and has extensive facilities in the UK... more